Sabina Schacher

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06).

R. Herrmann, R. Winterhalder, M. Borner, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

High thromboembolic event rate in patients with locally advanced oesophageal cancer during neoadjuvant therapy. An exploratory analysis of the prospective, randomised intergroup phase III trial SAKK 75/08

R. Winterhalder, H. Hawle, T. Ruhstaller, 2020, BMC Cancer.

Bevacizumab continuation versus no continuation after first-line chemo-bevacizumab therapy in patients with metastatic colorectal cancer: A randomized phase III noninferiority trial (SAKK 41/06).

R. Herrmann, R. Winterhalder, M. Borner, 2013 .